Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Taurine Market by Type (Food Grade, Pharmaceuticals Grade), by Source (Natural, Synthetic) and by Application (Food Beverages, Animal Feed, Dietary Supplements, Cosmetics and Personal Care, Dietary Supplements, Agriculture, Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2023-2032

A15463

Pages: NA

Charts: NA

Tables: NA

Taurine is a type of amino acid that is required for the body's protein synthesis. It is essential for infants' healthy development as well as individuals who are at danger of numerous disorders. Taurine is frequently added to milk for infants who are not yet old enough to manufacture it on their own. Similarly, those who are tube-fed and are on life support require enough amounts of the amino acid.

Taurine has the potential to save the lives of a number of patients. Congestive heart failure, liver illness, cystic fibrosis, and high blood pressure are all treated with it supplements. Alcoholism, autism, ADHD, epilepsy, vision disorders, and diabetes can all benefit from it.

COVID-19 Impact analysis

The taurine market is rapidly returning to pre-COVID levels, with a robust growth rate projected over the forecast period, owing to the economic recovery in most emerging countries. Unprecedented scenarios, however, as a result of the predicted third and subsequent waves, are casting a bleak picture.

Lockdowns around the world in 2020, as well as ongoing limitations in 2021, interrupted the supply chain, causing issues for Taurine manufacturers. Vendor profit margins will continue to be squeezed by fierce competition, price challenges, and altering consumer preferences.

Top Impacting Factors

  • The global taurine market is expected to be driven by an increase in personal development objectives, as well as increased demand for cosmetics and health awareness. Taurine energy drinks and supplements are essential for both highly trained athletes and the average young person to achieve their objectives. Taurine's numerous applications are expected to enhance the worldwide taurine market, as it has become a crucial growth product for everyone due to its numerous commercial applications.
  • The use of taurine is expected to rise dramatically, based on promising early research. According to current studies, long-term use of taurine can help reduce chemotherapy-induced kidney and liver damage. Taurine, when combined with coffee, not only lowers sleep and increases energy, however, it improves response times. This would give the taurine-based energy drink industry a big boost. The taurine market is expected to grow in the near future, thanks to increased R&D and new product releases.
  • During the projected period, the taurine market is expected to be driven by an increase in demand for taurine for bodybuilding and fitness. It helps to reduce dehydration, regulate blood pressure, and improve heart health, which is another important element driving the market. The industry is being propelled by an increase in the use of taurine supplements by athletes and sportspeople. The market is also being bolstered by increased demand from the pet food and energy drink industries. The industry is also expected to grow as people become more aware of the importance of having healthy skin.

Market Trends

  • Taurine and its analogues are thought to have anti-inflammatory and anti-neurotoxic properties, as well as the ability to stop tumor cells from multiplying. Mental and oxidative stress has both been shown to protect various organs from damage.
  • Taurine deficiency is linked to epilepsy, anxiety, depression, and hyperactivity. Taurine pills can help to alleviate these symptoms. It is also helpful in the treatment of weariness, alcoholism, and myotonia. It has also been linked to the preservation of vision in diabetics.
  • Taurine activates the glycerin receptor in animals, producing an anxiolytic effect and acting as a modulator or antianxiety drug in the central nervous system.In humans, daily injection of 1.5 grammes of taurine showed no effect on insulin secretion or sensitivity.
  • Energy drinks are becoming more popular around the world. Taurine is an amino acid that is included in energy drinks and is used to increase physical activity and bodybuilding. Taurine is found in Red Bull, a popular energy drink. It's widespread in both developed and underdeveloped countries.
  • The increased awareness of the importance of having healthy skin is also driving market demand, as it aids in the reduction of fine lines and wrinkles. Taurine's favorable effects in numerous foods, as well as the pharmaceutical sector, are driving the product's global market demand.

Key Benefits of the Report

  • This study presents the analytical depiction of the taurine industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the taurine market share.
  • The current market is quantitatively analyzed to highlight the taurine market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed taurine market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Report

  • Which are the leading players active in the ‘taurine market’?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is “taurine market” prediction in the future?
  • Which will be the niches at which players profiling with recent advancements should set a presence?
  • What are the driving factors and opportunities in the market?
  • What are the current trends and predicted trends?
  • What are the challenges faced in the "taurine market"?

Key Market Segments

  • By Type
    • Food Grade
    • Pharmaceuticals Grade
  • By Source
    • Natural
    • Synthetic
  • By Application
    • Food & Beverages
    • Animal Feed
    • Dietary Supplements
    • Cosmetics and Personal Care
    • Dietary Supplements
    • Agriculture
    • Pharmaceuticals
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • Stauber USA.
  • New Zealand Pharmaceuticals Ltd.
  • AuNutra Industries Inc.
  • MTC Industries Inc.
  • Penta Manufacturing Company
  • Hebi City Hexin Chem Ind. Co., Ltd.
  • Fuchi Pharmaceutical Co. Ltd
  • Ajinomoto Co., Inc.
  • The Honjo Chemical Corporation
  • Mitsui Chemicals, Inc.
  • JiangsuYuanyang Chemical Co. Ltd.
  • Kyowa Hakko Bio Co., Ltd.
  • QianjiangYongan Pharmaceutical Co., Ltd.
  • Foodchem International Corporation
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: TAURINE MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Food Grade

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Pharmaceuticals Grade

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: TAURINE MARKET, BY SOURCE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Source

    • 5.2. Natural

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Synthetic

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: TAURINE MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Food And Beverages

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Animal Feed

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Dietary Supplements

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Cosmetics And Personal Care

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Dietary Supplements

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Agriculture

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Pharmaceuticals

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

  • CHAPTER 7: TAURINE MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Source

      • 7.2.4. Market Size and Forecast, By Application

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Taurine Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Source
        • 7.2.6.3. Market Size and Forecast, By Application
      • 7.2.7. Canada Taurine Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Source
        • 7.2.7.3. Market Size and Forecast, By Application
      • 7.2.8. Mexico Taurine Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Source
        • 7.2.8.3. Market Size and Forecast, By Application
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Source

      • 7.3.4. Market Size and Forecast, By Application

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Taurine Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Source
        • 7.3.6.3. Market Size and Forecast, By Application
      • 7.3.7. Germany Taurine Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Source
        • 7.3.7.3. Market Size and Forecast, By Application
      • 7.3.8. Italy Taurine Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Source
        • 7.3.8.3. Market Size and Forecast, By Application
      • 7.3.9. Spain Taurine Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Source
        • 7.3.9.3. Market Size and Forecast, By Application
      • 7.3.10. UK Taurine Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Source
        • 7.3.10.3. Market Size and Forecast, By Application
      • 7.3.11. Russia Taurine Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Source
        • 7.3.11.3. Market Size and Forecast, By Application
      • 7.3.12. Rest Of Europe Taurine Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Source
        • 7.3.12.3. Market Size and Forecast, By Application
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Source

      • 7.4.4. Market Size and Forecast, By Application

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Taurine Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Source
        • 7.4.6.3. Market Size and Forecast, By Application
      • 7.4.7. Japan Taurine Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Source
        • 7.4.7.3. Market Size and Forecast, By Application
      • 7.4.8. India Taurine Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Source
        • 7.4.8.3. Market Size and Forecast, By Application
      • 7.4.9. South Korea Taurine Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Source
        • 7.4.9.3. Market Size and Forecast, By Application
      • 7.4.10. Australia Taurine Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Source
        • 7.4.10.3. Market Size and Forecast, By Application
      • 7.4.11. Thailand Taurine Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Source
        • 7.4.11.3. Market Size and Forecast, By Application
      • 7.4.12. Malaysia Taurine Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Source
        • 7.4.12.3. Market Size and Forecast, By Application
      • 7.4.13. Indonesia Taurine Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Source
        • 7.4.13.3. Market Size and Forecast, By Application
      • 7.4.14. Rest of Asia Pacific Taurine Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Source
        • 7.4.14.3. Market Size and Forecast, By Application
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Source

      • 7.5.4. Market Size and Forecast, By Application

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Taurine Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Source
        • 7.5.6.3. Market Size and Forecast, By Application
      • 7.5.7. South Africa Taurine Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Source
        • 7.5.7.3. Market Size and Forecast, By Application
      • 7.5.8. Saudi Arabia Taurine Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Source
        • 7.5.8.3. Market Size and Forecast, By Application
      • 7.5.9. UAE Taurine Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Source
        • 7.5.9.3. Market Size and Forecast, By Application
      • 7.5.10. Argentina Taurine Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Source
        • 7.5.10.3. Market Size and Forecast, By Application
      • 7.5.11. Rest of LAMEA Taurine Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Source
        • 7.5.11.3. Market Size and Forecast, By Application
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. MTC Industries Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Stauber USA.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Foodchem International Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. The Honjo Chemical Corporation

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. QianjiangYongan Pharmaceutical Co., Ltd.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. New Zealand Pharmaceuticals Ltd.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Ajinomoto Co., Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Kyowa Hakko Bio Co., Ltd.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. JiangsuYuanyang Chemical Co. Ltd.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Fuchi Pharmaceutical Co. Ltd

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Penta Manufacturing Company

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Mitsui Chemicals, Inc.

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. AuNutra Industries Inc.

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

    • 9.14. Hebi City Hexin Chem Ind. Co., Ltd.

      • 9.14.1. Company Overview

      • 9.14.2. Key Executives

      • 9.14.3. Company Snapshot

      • 9.14.4. Operating Business Segments

      • 9.14.5. Product Portfolio

      • 9.14.6. Business Performance

      • 9.14.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL TAURINE MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL TAURINE MARKET FOR FOOD GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL TAURINE MARKET FOR PHARMACEUTICALS GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL TAURINE MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL TAURINE MARKET FOR NATURAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL TAURINE MARKET FOR SYNTHETIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL TAURINE MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL TAURINE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL TAURINE MARKET FOR ANIMAL FEED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL TAURINE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL TAURINE MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL TAURINE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL TAURINE MARKET FOR AGRICULTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL TAURINE MARKET FOR PHARMACEUTICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL TAURINE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA TAURINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. U.S. TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 22. U.S. TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. CANADA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 25. CANADA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE TAURINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ITALY TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 41. ITALY TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. UK TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. UK TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 47. UK TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC TAURINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. CHINA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 60. CHINA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. INDIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 66. INDIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA TAURINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. UAE TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 99. UAE TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 100. UAE TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA TAURINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA TAURINE, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA TAURINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. MTC INDUSTRIES INC.: KEY EXECUTIVES
  • TABLE 108. MTC INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 109. MTC INDUSTRIES INC.: OPERATING SEGMENTS
  • TABLE 110. MTC INDUSTRIES INC.: PRODUCT PORTFOLIO
  • TABLE 111. MTC INDUSTRIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. STAUBER USA.: KEY EXECUTIVES
  • TABLE 113. STAUBER USA.: COMPANY SNAPSHOT
  • TABLE 114. STAUBER USA.: OPERATING SEGMENTS
  • TABLE 115. STAUBER USA.: PRODUCT PORTFOLIO
  • TABLE 116. STAUBER USA.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. FOODCHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
  • TABLE 118. FOODCHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 119. FOODCHEM INTERNATIONAL CORPORATION: OPERATING SEGMENTS
  • TABLE 120. FOODCHEM INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 121. FOODCHEM INTERNATIONAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. THE HONJO CHEMICAL CORPORATION: KEY EXECUTIVES
  • TABLE 123. THE HONJO CHEMICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 124. THE HONJO CHEMICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 125. THE HONJO CHEMICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 126. THE HONJO CHEMICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 128. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 129. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 130. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 131. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. NEW ZEALAND PHARMACEUTICALS LTD.: KEY EXECUTIVES
  • TABLE 133. NEW ZEALAND PHARMACEUTICALS LTD.: COMPANY SNAPSHOT
  • TABLE 134. NEW ZEALAND PHARMACEUTICALS LTD.: OPERATING SEGMENTS
  • TABLE 135. NEW ZEALAND PHARMACEUTICALS LTD.: PRODUCT PORTFOLIO
  • TABLE 136. NEW ZEALAND PHARMACEUTICALS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. AJINOMOTO CO., INC.: KEY EXECUTIVES
  • TABLE 138. AJINOMOTO CO., INC.: COMPANY SNAPSHOT
  • TABLE 139. AJINOMOTO CO., INC.: OPERATING SEGMENTS
  • TABLE 140. AJINOMOTO CO., INC.: PRODUCT PORTFOLIO
  • TABLE 141. AJINOMOTO CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. KYOWA HAKKO BIO CO., LTD.: KEY EXECUTIVES
  • TABLE 143. KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT
  • TABLE 144. KYOWA HAKKO BIO CO., LTD.: OPERATING SEGMENTS
  • TABLE 145. KYOWA HAKKO BIO CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 146. KYOWA HAKKO BIO CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. JIANGSUYUANYANG CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 148. JIANGSUYUANYANG CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 149. JIANGSUYUANYANG CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 150. JIANGSUYUANYANG CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 151. JIANGSUYUANYANG CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. FUCHI PHARMACEUTICAL CO. LTD: KEY EXECUTIVES
  • TABLE 153. FUCHI PHARMACEUTICAL CO. LTD: COMPANY SNAPSHOT
  • TABLE 154. FUCHI PHARMACEUTICAL CO. LTD: OPERATING SEGMENTS
  • TABLE 155. FUCHI PHARMACEUTICAL CO. LTD: PRODUCT PORTFOLIO
  • TABLE 156. FUCHI PHARMACEUTICAL CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. PENTA MANUFACTURING COMPANY: KEY EXECUTIVES
  • TABLE 158. PENTA MANUFACTURING COMPANY: COMPANY SNAPSHOT
  • TABLE 159. PENTA MANUFACTURING COMPANY: OPERATING SEGMENTS
  • TABLE 160. PENTA MANUFACTURING COMPANY: PRODUCT PORTFOLIO
  • TABLE 161. PENTA MANUFACTURING COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. MITSUI CHEMICALS, INC.: KEY EXECUTIVES
  • TABLE 163. MITSUI CHEMICALS, INC.: COMPANY SNAPSHOT
  • TABLE 164. MITSUI CHEMICALS, INC.: OPERATING SEGMENTS
  • TABLE 165. MITSUI CHEMICALS, INC.: PRODUCT PORTFOLIO
  • TABLE 166. MITSUI CHEMICALS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. AUNUTRA INDUSTRIES INC.: KEY EXECUTIVES
  • TABLE 168. AUNUTRA INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 169. AUNUTRA INDUSTRIES INC.: OPERATING SEGMENTS
  • TABLE 170. AUNUTRA INDUSTRIES INC.: PRODUCT PORTFOLIO
  • TABLE 171. AUNUTRA INDUSTRIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. HEBI CITY HEXIN CHEM IND. CO., LTD.: KEY EXECUTIVES
  • TABLE 173. HEBI CITY HEXIN CHEM IND. CO., LTD.: COMPANY SNAPSHOT
  • TABLE 174. HEBI CITY HEXIN CHEM IND. CO., LTD.: OPERATING SEGMENTS
  • TABLE 175. HEBI CITY HEXIN CHEM IND. CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 176. HEBI CITY HEXIN CHEM IND. CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL TAURINE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL TAURINE MARKET
  • FIGURE 3. SEGMENTATION TAURINE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN TAURINE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALTAURINE MARKET
  • FIGURE 11. TAURINE MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. TAURINE MARKET FOR FOOD GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. TAURINE MARKET FOR PHARMACEUTICALS GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. TAURINE MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 15. TAURINE MARKET FOR NATURAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. TAURINE MARKET FOR SYNTHETIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. TAURINE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. TAURINE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TAURINE MARKET FOR ANIMAL FEED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TAURINE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TAURINE MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TAURINE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TAURINE MARKET FOR AGRICULTURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TAURINE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: TAURINE MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. MTC INDUSTRIES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. MTC INDUSTRIES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. MTC INDUSTRIES INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. STAUBER USA.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. STAUBER USA.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. STAUBER USA.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. FOODCHEM INTERNATIONAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. FOODCHEM INTERNATIONAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. FOODCHEM INTERNATIONAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. THE HONJO CHEMICAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. THE HONJO CHEMICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. THE HONJO CHEMICAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. QIANJIANGYONGAN PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. NEW ZEALAND PHARMACEUTICALS LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. NEW ZEALAND PHARMACEUTICALS LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. NEW ZEALAND PHARMACEUTICALS LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. AJINOMOTO CO., INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. AJINOMOTO CO., INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. AJINOMOTO CO., INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. KYOWA HAKKO BIO CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. KYOWA HAKKO BIO CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. KYOWA HAKKO BIO CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. JIANGSUYUANYANG CHEMICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. JIANGSUYUANYANG CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. JIANGSUYUANYANG CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. FUCHI PHARMACEUTICAL CO. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. FUCHI PHARMACEUTICAL CO. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. FUCHI PHARMACEUTICAL CO. LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. PENTA MANUFACTURING COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. PENTA MANUFACTURING COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. PENTA MANUFACTURING COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 65. MITSUI CHEMICALS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 66. MITSUI CHEMICALS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 67. MITSUI CHEMICALS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 68. AUNUTRA INDUSTRIES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 69. AUNUTRA INDUSTRIES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 70. AUNUTRA INDUSTRIES INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 71. HEBI CITY HEXIN CHEM IND. CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 72. HEBI CITY HEXIN CHEM IND. CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 73. HEBI CITY HEXIN CHEM IND. CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Taurine Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue